Archives
- January 2025 (3)
- December 2024 (5)
- November 2024 (4)
- October 2024 (5)
- September 2024 (6)
- August 2024 (5)
- July 2024 (6)
- June 2024 (6)
- May 2024 (9)
- April 2024 (8)
- March 2024 (9)
- February 2024 (6)
- January 2024 (6)
- December 2023 (2)
- November 2023 (5)
- October 2023 (11)
- September 2023 (13)
- August 2023 (13)
- July 2023 (19)
- June 2023 (19)
- May 2023 (20)
- April 2023 (22)
- March 2023 (23)
- February 2023 (22)
- January 2023 (28)
- December 2022 (25)
- November 2022 (18)
- October 2022 (22)
- September 2022 (26)
- August 2022 (30)
- July 2022 (33)
- June 2022 (22)
- May 2022 (30)
- April 2022 (28)
- March 2022 (29)
- February 2022 (15)
- January 2022 (4)
- December 2021 (4)
- November 2021 (1)
- October 2021 (2)
- September 2021 (2)
- August 2021 (6)
- July 2021 (9)
- May 2021 (8)
- April 2021 (15)
- March 2021 (7)
- January 2021 (5)
- October 2020 (5)
- September 2020 (10)
- August 2020 (1)
- July 2020 (2)
- June 2020 (3)
- April 2020 (1)
- March 2020 (1)
- February 2020 (1)
- January 2020 (4)
- December 2019 (1)
- August 2019 (1)
- October 2018 (2)
- September 2018 (3)
- August 2018 (2)
- July 2018 (1)
- April 2018 (1)
- March 2018 (2)
- February 2018 (1)
- December 2017 (3)
- November 2017 (1)
- October 2017 (3)
- September 2017 (2)
- August 2017 (6)
- June 2017 (1)
- May 2017 (3)
- April 2017 (2)
- March 2017 (6)
- February 2017 (8)
- January 2017 (5)
- December 2016 (7)
- November 2016 (7)
- October 2016 (2)
- September 2016 (5)
- August 2016 (4)
- July 2016 (2)
- June 2016 (22)
- May 2016 (17)
- April 2016 (13)
- March 2016 (13)
- February 2016 (16)
- January 2016 (13)
- December 2015 (27)
- November 2015 (42)
- October 2015 (40)
- September 2015 (49)
- August 2015 (43)
- July 2015 (28)
- June 2015 (38)
- May 2015 (46)
- April 2015 (67)
- March 2015 (49)
- February 2015 (28)
- January 2015 (20)
- December 2014 (23)
- November 2014 (18)
- October 2014 (20)
- September 2014 (30)
- August 2014 (28)
- July 2014 (24)
- June 2014 (25)
- May 2014 (12)
- April 2014 (8)
- March 2014 (13)
- February 2014 (5)
- January 2014 (2)
- December 2013 (7)
- November 2013 (11)
- October 2013 (25)
- September 2013 (30)
- August 2013 (34)
- July 2013 (33)
- June 2013 (46)
- May 2013 (47)
- April 2013 (4)
- March 2013 (3)
- March 2011 (1)
- December 2008 (1)
- November 2008 (1)
- July 2008 (3)
- April 2008 (3)
- February 2008 (1)
- December 2007 (3)
- November 2007 (2)
- October 2007 (5)
- September 2007 (3)
- August 2007 (3)
- July 2007 (2)
- June 2007 (1)
- May 2007 (2)
- April 2007 (4)
- March 2007 (23)
- February 2007 (4)
- January 2007 (6)
- December 2006 (2)
- October 2006 (1)
- June 2006 (1)
- April 2005 (1)
- July 2003 (1)
- April 2003 (1)
- April 2002 (1)
- February 2001 (1)
- November 2000 (1)
- April 2000 (1)
- October 1999 (1)
- September 1999 (2)
- June 1999 (1)
- May 1999 (3)
- March 1999 (1)
- October 1998 (1)
- August 1998 (1)
- July 1998 (2)
- May 1998 (4)
- April 1998 (4)
- February 1998 (1)
- December 1997 (2)
- November 1997 (1)
- October 1997 (2)
- September 1997 (2)
- July 1997 (4)
- June 1997 (2)
- May 1997 (1)
- April 1997 (1)
- March 1997 (1)
- December 1996 (1)
- May 1996 (1)
Categories
- 念一瓢酌 Memory (28)
- 思一瓢酌 Thinking (1,003)
- 混沌一瓢酌 chaos (284)
- 獨語一瓢酌 soliloquy (441)
- 生一瓢酌 Life (223)
- 讀一瓢酌 Read (1,014)
- 遊一瓢酌 Traveling (47)
- 饒舌一瓢酌 Rapping (244)
Meta
Author Said Something
Daily Archives: September 19, 2024
Alzheimer’s Disease Decoded: The History, Present, And Future Of Alzheimer’s Disease And Dementia (2022)
這本 “Alzheimer’s Disease Decoded: The History, Present, And Future Of Alzheimer’s Disease And Dementia (2022)” 書旨在以全面的方式向個人介紹、教育和告知阿茲海默症。其範圍涵蓋從疾病的發現、流行病學和背後的基本生物學原理,到用於治療阿茲海默症的先進幹細胞療法。它採用「全球」視角來看待阿茲海默症,並包括來自世界各國的流行病學數據和科學。 阿茲海默症是世界各國都存在的一個快速成長的問題。這是第一本也是唯一一本涵蓋阿茲海默症的綜合書籍,包括癡呆症和阿茲海默症研究領域的最新文獻和科學進展。 市面上大多數關注阿茲海默症的書籍都是針對照護者的,作為如何應對患有疾病的親人的實用建議。相反,這本書是一本綜合性的科普書,任何有興趣了解疾病的人都可以閱讀。 Jefferson Chen 博士是醫學博士、博士、合著者,參與了世界上第一個使用分流器治療阿茲海默症的外科臨床試驗。他親自參與了阿茲海默症患者的臨床試驗,並治療常壓腦積水(NPH)(通常被誤診為阿茲海默症),這為他提供了獨特的視角。 這本書吸引了廣泛的讀者,無論他們的科學或教育背景如何。 xxxxxxxxxx 阿茲海默症已成為全球人口老化的標誌性疾病,也是日益嚴重的公共衛生威脅。與許多其他疾病不同,阿茲海默症不僅在很大程度上影響患者,而且還給他們的朋友、家人和社區帶來巨大的情感和經濟負擔。所有核准的治療方法只能略微提高受影響個體的認知能力。數百項失敗的臨床試驗反映出阿茲海默症背後的神秘病理學。本書講述科學家、醫生和患者與阿茲海默症進行鬥爭的故事,並向過程中喪生的人們致敬。 這場戰爭有多條戰線 —— 從致力於終結阿茲海默症的個人和政治努力,到為改變阿茲海默症患者認知惡化軌跡而進行的科學鬥爭。這本書努力了解周圍人的故事以及他們患阿茲海默症的個人經歷。書中幾乎採訪的每個人都有與阿茲海默症相關的個人故事,無論是他們自己的父母、姻親還是受到影響的家人朋友。儘管阿茲海默症在我們的社會中很普遍且具有重要意義,但沒有一本面向公眾的書簡潔地涵蓋了該疾病的歷史、科學和未來。這本書希望是講述阿茲海默症的故事,從它的歷史到治療這種疾病的努力如此困難和笨拙的原因。希望任何對阿茲海默症感興趣的人都可以透過這本書更好地了解在科學、政治和治療上在終結阿茲海默症方面的進展。目前雖然還沒有任何美國食品和藥物管理局 ( U.S. Food and Drug Administration,FDA ) 批准的有效藥物或療法,但有許多有希望的潛在治療方法即將出現。 對熟悉阿茲海默症興趣的人經常問:我們在成功根除這種疾病方面取得了甚麼進展。快速進行谷歌搜尋或觀看任何健康新聞源,很容易就會產生大量有關阿茲海默症的下一個「治癒方法」的新聞標題和廣告。很多時候,這些說法是誤導性的或完全錯誤的 —— 通常是基於順勢療法或未經證實的療法。這些「治癒」不治之症的說法對於研究該疾病及其治療方法的科學努力是有害的。通常,這些說法會給阿茲海默症患者及其家人帶來錯誤的希望,但不幸的是,這些說法的動機是經濟利益。這些偽科學家向阿茲海默症患者提供治癒方法的承諾,卻沒有履行科學界的倫理和道德義務,無法將安全、經過驗證和基於證據的療法推向市場。本書立埸在研究了生產所謂「療法」的公司的說法後,不斷提醒醫生們的職責世界各地的科學家 “首先不造成傷害”,不要給患有末期疾病的患者提供虛假的希望。但當談到世界各地實驗室正在進行的真正科學研究時,治療的希望正在慢慢實現。簡而言之,本書對阿茲海默症的治療或治癒方法的出現持謹慎樂觀的態度 。儘管目前還沒有藥物、治療方法或巫術技術可以有效阻止疾病的進展,但許多有前景的療法即將出現。目前,市場上有幾種 … Continue reading
Posted in 思一瓢酌 Thinking, 讀一瓢酌 Read
Leave a comment